{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:11:32Z","timestamp":1791486692270,"version":"4.3.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/wad.0b013e3181611024","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T10:08:57Z","timestamp":1236247737000},"page":"21-29","source":"Crossref","is-referenced-by-count":50,"title":["A Randomized, Double-blind, Placebo Controlled-trial of Triflusal in Mild Cognitive Impairment"],"prefix":"10.1097","volume":"22","author":[{"given":"Teresa","family":"G\u00f3mez-Isla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Blesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merce","family":"Boada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Clarim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodoro Del","family":"Ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"G\u00f3mez-Ans\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Manubens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Mart\u00ednez-Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Pe\u00f1a-Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"R2-4-20210128","first-page":"1","article-title":"Mild Cognitive Impairment: Aging to Alzheimer's Disease","author":"Petersen","year":"2003"},{"key":"R3-4-20210128","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archneur.63.5.665","article-title":"Neuropathologic features of amnestic mild cognitive impairment","volume":"63","author":"Petersen","year":"2006","journal-title":"Arch Neurol"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","article-title":"Early detection of dementia: mild cognitive impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"56","author":"Petersen","year":"2001","journal-title":"Neurology"},{"key":"R5-4-20210128","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat Med"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible neuroprotective factors for Alzheimer's disease: a review of 17 epidemiological studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","article-title":"A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment","volume":"30","author":"Thal","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00018-007-6516-1","article-title":"Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases","volume":"64","author":"Lleo","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"R12-4-20210128","first-page":"CD004296","article-title":"Triflusal for preventing serious vascular events in people at high risk","volume":"20","author":"Costa","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bjp.0702441","article-title":"4-trifluoromethyl derivates of salicylate, Triflusal and its main metabolito 2-hydroxy-4-trifluoromethylbenzoic acids, are potent inhibitors of nuclear factor KB activation","volume":"126","author":"Bayon","year":"1999","journal-title":"Br J Pharmacol"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3940(00)01202-7","article-title":"Oral administration of the anti-inflammatory substance results in the downregulation of constitutive transcription factor NF-kB in the postnatal rat brain","volume":"288","author":"Acarin","year":"2000","journal-title":"Neurosci Lett"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/hs1001.097243","article-title":"Triflusal posttreatment inhibits glial nuclear factor-KB, downregulates the glial response, and its neuroprotective in an excitotoxic injury model in postnatal brain","volume":"32","author":"Acarin","year":"2001","journal-title":"Stroke"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1161\/01.STR.0000028184.80776.58","article-title":"Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate Triflusal after postnatal excitotoxic damage","volume":"33","author":"Acarin","year":"2002","journal-title":"Stroke"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1161\/01.STR.0000173405.02425.d6","article-title":"Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: II. Effects of triflusal","volume":"36","author":"Whitehead","year":"2005","journal-title":"Stroke"},{"key":"R18-4-20210128","first-page":"99","article-title":"Shortened version of the Barcelona test (I): subtests and normal profiles","volume":"12","author":"Pe\u00f1a-Casanova","year":"1997","journal-title":"Neurologia"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"R20-4-20210128","first-page":"641","article-title":"Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease","volume":"24","author":"Morris","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ana.410070516","article-title":"Pathological verification of ischemic score in differentiation of dementias","volume":"7","author":"Rosen","year":"1980","journal-title":"Ann Neurol"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"R25-4-20210128","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"issue":"2","key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's disease assessment scale that broaden its scope. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Mohs","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/01688638408401233","article-title":"Cued recall in amnesia","volume":"6","author":"Buschke","year":"1984","journal-title":"J Clin Neuropsychol"},{"key":"R29-4-20210128","first-page":"206","article-title":"Le test de copie d'une figure complexe","volume":"30","author":"Osterrieth","year":"1944","journal-title":"Arch Psychol"},{"key":"R30-4-20210128","article-title":"Wechsler Adult Intelligence Scale\u2014Revised","author":"Wechsler","year":"1981"},{"key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.ps.45.020194.000245","article-title":"Multilingual Aphasia Examination. Iowa City, Iowa: ASA Associates, Benton AL. Neuropsychological assessment","volume":"45","author":"Benton","year":"1994","journal-title":"Annu Rev Psychol"},{"key":"R32-4-20210128","article-title":"Contributions to Neuropsychological Assessment","author":"Benton","year":"1983"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the trail making test as an indication of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Motor Skills"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp.64.5.588","article-title":"CLOX: an executive clock drawing task","volume":"64","author":"Royall","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N Engl J Med"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/brain\/124.1.96","article-title":"Stability of the preclinical episodic memory deficit in Alzheimer's disease","volume":"124","author":"B\u00e4ckman","year":"2001","journal-title":"Brain"},{"key":"R38-4-20210128","first-page":"23","article-title":"Cognitive deficits in preclinical Alzheimer's disease","volume":"179","author":"Small","year":"2003","journal-title":"Acta Neurol Scand (Suppl)"},{"key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/13825580500320707","article-title":"Alzheimer's disease patients' cognitive status and course years prior to symptom recognition","volume":"14","author":"Cerhan","year":"2007","journal-title":"Aging Neuropsychol Cogn"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/01.wnl.0000265594.23511.16","article-title":"A plateau in pre-Alzheimer memory decline. Evidence for compensatory mechanisms?","volume":"69","author":"Smith","year":"2007","journal-title":"Neurology"}],"container-title":["Alzheimer Disease & Associated Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002093-200801000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:37:56Z","timestamp":1786037876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002093-200801000-00004"}},"subtitle":["The TRIMCI Study"],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/wad.0b013e3181611024","relation":{},"ISSN":["0893-0341"],"issn-type":[{"value":"0893-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}